pulseTV

VIDEO: Tricuspid Device Clinical Trial Overview

Heart Valve Technology | July 10, 2018

Ori Ben-Yehuda, M.D., executive director of the Cardiovascular Research Foundation Clinical Trial Center, discusses the latest data from clinical trials focusing on transcatheter tricuspid valve repair (TTVR) technologies, at the 2018 Transcatheter Valve Therapies (TVT) annual meeting in Chicago.

 

Related Transcatheter Tricuspid Valve Content

Minneapolis Heart Institute Foundation Enrolls First Patient in TRILUMINATE Tricuspid Repair Trial

Positive, Sustained Improvement at One Year in SCOUT I Transcatheter Tricuspid Repair Trial

Gate Bioprosthesis Used in Canada's First Transcatheter Valve Replacement for Tricuspid Regurgitation

VIDEO: Tricuspid Valve Imaging and Interventions Developing Hand-in-hand 

VIDEO: Mitral and Tricuspid Valve Repair Technologies

 

 

Cath Lab

Heart Valve Technology | July 10, 2018

Ori Ben-Yehuda, M.D., executive director of the Cardiovascular Research Foundation Clinical Trial Center, discusses the latest data from clinical trials focusing on transcatheter tricuspid valve repair (TTVR) technologies, at the 2018 Transcatheter Valve Therapies (TVT) annual meeting in Chicago.

 

Related Transcatheter Tricuspid Valve Content

Minneapolis Heart Institute Foundation Enrolls First Patient in TRILUMINATE Tricuspid Repair Trial

Positive, Sustained Improvement at One Year in SCOUT I Transcatheter Tricuspid Repair Trial

Gate Bioprosthesis Used in Canada's First Transcatheter Valve Replacement for Tricuspid Regurgitation

VIDEO: Tricuspid Valve Imaging and Interventions Developing Hand-in-hand 

VIDEO: Mitral and Tricuspid Valve Repair Technologies

 

 

Cardiovascular Ultrasound | July 10, 2018

DAIC Editor Dave Fornell highlights some of the most innovative new technology on the show floor of the American Society of Echocardiography (ASE) 2018 meeting. The segments include virtual reality workstations, advanced 3-D cardiac ultrasound quantification and visualization, improved echo-fluoro image fusion technology, and imaging aided by artificial intelligence.

 

 

 

Heart Valve Technology | July 05, 2018

Rebecca Hahn, M.D., professor of medicine and director of interventional echocardiography, Columbia University Medical Center, New York, explains that techniques for imaging the tricuspid valve, the  advanced study of its disease etiology and the rapid development of transcatheter devices to treat tricuspid valve disease are all developing together. She spoke on these topics during sessions at both the American Society of Echocardiography (ASE) 2018 meeting and at the Transcatheter Valve Therapies (TVT) conference in June. 

Related Transcatheter Tricuspid Valve Content:
Recent Advances in Transcatheter Valve Technology

VIDEO: Mitral and Tricuspid Valve Repair Technologies — interview with Azeem Latib, M.D.

VIDEO: Transcatheter Tricuspid Valve Repair and Replacement Technologies — interview with Rebecca Hahn, M.D.

Minneapolis Heart Institute Foundation Enrolls First Patient in TRILUMINATE Tricuspid Repair Trial

Positive, Sustained Improvement at One Year in SCOUT I Transcatheter Tricuspid Repair Trial

Gate Bioprosthesis Used in Canada's First Transcatheter Valve Replacement for Tricuspid Regurgitation

Cardiovascular Ultrasound | June 28, 2018

This is a demonstration of the the Philips TrueVue photo-realistic rendering and lighting source technology. This example highlights a transcatheter ASD closure with two Amplatzer occluders. The technology allows users to changing the lighting conditions to improve contrast. The light source can also be moved around to change the shadows and add more depth perception. The light source also can be pushed through the tissue to back light the anatomical structures, as shown in this example at the American Society of Echocardiography (ASE) 2018 meeting. The backlighting confirms a gap at the top of the image where part of the septal defect remains exposed. 

Find more videos and news from ASE 

Cath Lab | May 07, 2018

Imran Ahmad, M.D., medical director of interventional cardiology, explains some of the new technologies his labs have integrated. He also explains how incorporation of his suburban hospital with Northwestern’s Bluhm Cardiovascular Institute has enabled a new TAVR program.

Read the related article on this hospital, "Hospital Consolidation May Increase Access to TAVR, New Cardiac Technologies."

View a 360 photo in his cath lab.

 

Heart Valve Technology | April 18, 2018

Northwestern Medicine has purchased several smaller Chicago suburban hospitals in the past few years to expand its healthcare system. This has enabled these smaller community hospitals to offer new, cutting-edge cardiovascular medical technologies much sooner than might have otherwise been possible due to its association with Northwestern Medicine's luminary Bluhm Cardiovascular Institute in Chicago. Central DuPage Hospital is one of the newer hospitals in the network and now offers transcatheter aortic valve replacements (TAVR), transcatheter leadless pacemakers, minimally invasive left atrial appendage (LAA) occlusions and the latest surgical valve replacement technologies. 

Cath Lab | March 27, 2018

Roxana Mehran, M.D., FACC, FACP, FCCP, FESC, FAHA, FSCAI, professor of medicine and director of interventional cardiovascular research and clinical trials at the Zena and Michael A. Wiener Cardiovascular Institute at Mount Sinai School of Medicine. She spoke on how to avoid acute kidney injury (AKI) and contrast-induced nephropathy (CIN) at the American College of Cardiology (ACC) 2018 meeting.  Watch the VIDEO "How to Avoid Acute Kidney Injury in the Cath Lab," an interview with Hitinder Gurm, M.D.
 

 

 

Intravascular Imaging | March 27, 2018

A discussion with Ron Waksman, M.D., associate director of the division of cardiology and director of cardiovascular research and advanced education at MedStar Heart Institute, and professor of medicine (cardiology) at Georgetown University. He explained the ongoing clinical trials using near infrared spectroscopy to detect lipid rich plaque in the coronary arteries. He spoke to DAIC at the 2018 American College of Cardiology (ACC) meeting.

Cardiac Diagnostics | March 26, 2018

James Januzzi, M.D., Roman W. DeSanctis Endowed Distinguished Clinical Scholar in Medicine, and director of the Dennis and Marilyn Barry Fellowship in cardiology research at Massachusetts General Hospital, discusses the use of highly sensitive troponin testing for chest pain in the emergency department (ED). Read the related articles New Heart Attack Evaluation Cuts Unnecessary Tests, Time in ER and Highly-sensitive Troponin Test Can Detect Myocardial Injury After Non-Cardiac Surgery.

 

ACC | March 21, 2018

DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at the 2018 meeting of the American College of Cardiology (ACC). Find links to other videos and the ACC 2018 Late-Breaking Trials.
 

 

Cath Lab | March 15, 2018

A discussion with Hitinder Gurm, M.D., MBBS, FACC, professor, internal medicine, and associate chief clinical officer, University of Michigan Health System, at the 2018 American College of Cardiology (ACC) meeting.  For more information, read the article "Understanding Contrast-Induced Nephropathy."

Watch the VIDEO "Strategies to Avoid Acute Kidney Injury Caused by Cath Lab Contrast," an interview with Roxana Mehran, M.D.

 

Heart Valve Technology | March 15, 2018

Insights from the STS/ACC TVT Transcatheter Valve Registry, presented at the American College of Cardiology (ACC) 2018 meeting by Sammy Elmariah, M.D., MPH, interventional structural heart disease, Massachusetts General Hospital. See the following related content for other insights into transcatheter aortic valve replacement technology:

VIDEO: Clinical Outcomes With the Lotus TAVR Valve

CoreValve TAVR System Shows Strong Long-Term Performance in Clinical Trials

VIDEO: TAVR For Asymptomatic Severe Aortic Stenosis

VIDEO: Conscious Sedation for TAVR Procedures

VIDEO: Transcaval Access in TAVR Procedures

• VIDEO: TAVR for Degenerated Surgical Valves — Valve-in-Valve TAVR Procedures

FFR Technologies | March 15, 2018

An economic analysis of the DEFINE-FLAIR study comparing FFR vs. iFR, found a cost savings of nearly $900. The late-breaking session was presented at the 2018 American College of Cardiology (ACC) meeting by Manesh Patel, M.D., investigator and member of the study steering committee, and chief, division of cardiology, Duke University. Read more about the economic study. Watch a VIDEO on the 2017 results of the DEFINE-FLAIR and SWED-HEART iFR vs. FFR trials

Sudden Cardiac Arrest | March 14, 2018

The Zoll LifeVest is a temporary, wearable defibrillator designed as a safety net for patients, especially those being evaluated for a permanent implantable cardioverter defibrillator (ICD). The Vest Prevention of Early Sudden Death Trial (VEST), presented at ACC 2018, was the first randomized, controlled, multi-center trial of the wearable cardioverter defibrillator. It looked to see if this device could effectively reduce sudden death in patients who had recently suffered a heart attack and had reduced heart function. Read more about the VEST Trial. 

Heart Valve Technology | March 02, 2018

Sammy Elmariah, M.D., MPH, interventional structural heart disease, Massachusetts General Hospital, discusses the progression of using transcatheter heart valves to replace surgical valves at ACC.17. See the following related content for other insights into transcatheter aortic valve replacement technology:

 VIDEO: Clinical Outcomes With the Lotus TAVR Valve

• CoreValve TAVR System Shows Strong Long-Term Performance in Clinical Trials

• VIDEO: TAVR For Asymptomatic Severe Aortic Stenosis

• VIDEO: Conscious Sedation for TAVR Procedures

• VIDEO: Transcaval Access in TAVR Procedures

 

February 22, 2018

This video details the first use of a new protocol at The Ohio State University’s Wexner Medical Center to start sudden cardiac arrest patients on extracorporeal membrane oxygenation (ECMO) en route to the hospital, where they are sent straight to the cath lab. According to the hospital, the protocol has improved cardiac arrest survival rates from 0 to nearly 40 percent. Video courtesy of The Ohio State University Wexner Medical Center.

Read the article “New Protocol Gives Patients Fighting Chance to Survive Cardiac Arrest”

Radial Access | February 16, 2018

The father of transradial artery access, Ferdinand Kiemeneij, M.D., Ph.D., interventional cardiologist, The Netherlands, explains how and why he first implemented the use of radial access and explains how the technique expanded beyond his cath lab to spread around the world. Read the article "Transradial Access Celebrates 25 Years". Watch the VIDEO "New Frontiers in Radial Access." Keep up to date on radial access news with DAIC's radial access channel. 

Cath Lab | January 04, 2018

Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif., and former cardiology department manager at the cardiac cath lab at the Jesse Brown VA Medical Center in Chicago, offers insights from her SCAI Boot Camp presentation at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. She discusses implementing new techniques and technologies, drawing from her experience implementing radial access programs. Here are links to a couple articles she wrote on the topic “Tips When Prepping for Radial Procedures” and “How to Contend With Transradial Artery Perforation.”

Heart Valve Technology | January 04, 2018

Adam Greenbaum, M.D., co-director, Center for Structural Heart Disease, Henry Ford Hospital, Detroit, explains how his center is already performing off-label transcatheter mitral valve implantations in patients who otherwise have no more options. He also discusses some of the new transcatheter mitral valve technologies in development. Watch the VIDEO “Mitral and Tricuspid Valve Repair Technologies.”  Watch a VIDEO of Greenbaum explaining his use of venous-to-aortic transcaval access in TAVR.

Angiography | November 22, 2017

Shimadzu demonstrated its Trinias Interventional X-ray System at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. The system offers several features to enable improved patient access and procedural guidance at a lower radiation dose than previous generation angiography systems. For more information visit www.shimadzu.com/med/products/angio.

Radial Access | November 22, 2017

Mladen I. Vidovich, M.D., FACC, FSCAI, chief, section of cardiology, Jesse Brown VA Medical Center, Chicago, and associate professor of medicine at the University of Illinois at Chicago, discusses some of the current techniques and issues involved with radial artery access. DAIC spoke to him at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. Read articles he authored, including “Radiation Exposure Related to Transradial Access” and “Vascular Closure Devices Aid Closure of Large Access Sites.”

 

Medical 3-D Printing | November 17, 2017

Dee Dee Wang, M.D., Director, Structural Heart Imaging at Henry Ford Hospital, Detroit, explains how her center uses 3-D printing and computer aided design (CAD) software to improve patient outcomes. She spoke to DAIC at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. Read the articles “The Use of 3-D Printing in Cardiology” and “Henry Ford Hospital Study Shows 3-D Imaging Improves Fixing Broken Hearts.”  

Stents Bifurcation | November 15, 2017

Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at Morristown Medical Center, part of Atlantic Health System, explains his experience with the Tryton Side Branch stent in both clinical practice and as an investigator in the Tryton Pivotal IDE Trial. Read the article “Data Published for Pivotal Trial for Tryton Side Branch Stent,” and about the regulatory clearance “FDA Clears First Dedicated Coronary Bifurcation Stent.”

TCT | November 15, 2017

DAIC Editor Dave Fornell shows some of the innovations displayed on the expo floor at the 2017 Transcatheter Cardiovascular Therapeutics (TCT). Hear what Cardiovascular Research Foundation (CRF) President and CEO Juan Granada, M.D., feels are the hottest technologies to watch. 

FFR Technologies | November 15, 2017

A discussion with William Fearon, M.D. director of interventional cardiology, Stanford University Medical Center, about the FAST-FFR Trial he is heading. It is comparing wire-based fractional flow reserve (FFR) to angiography image-derived FFR. The technology may open the door to wider use of FFR by eliminating costs, disruption and extra time in the cath lab workflow, the use of pressure wires and eliminate the need for adenosine. Watch a VIDEO on the early adoption of FFR-CT technology to assess chest pain patients

Related FFRangio Content

CathWorks Receives CPT Code for Non-invasive FFRangio Measurements During PCI

Heart Valve Technology | November 15, 2017

Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, is the principal investigator for the Lotus valve’s U.S. pivotal trial. He explains what the clinical data to date has been for this new transcatheter aortic valve replacement (TAVR) device, which will likely become the third available on the U.S. market. Read the article "Lotus TAVR System Shows Superior Efficacy to CoreValve in Global REPRISE III Trial."

 

Left Atrial Appendage (LAA) Occluders | November 14, 2017

Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospital, N.Y., explains the latest Watchman left atrial appendage (LAA) occluder study data presented at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. Watch the VIDEO “Post-FDA Approval Experience of LAA Occluders,” with David Holmes, M.D. Watch a VIDEO interview with Reddy at Heart Rhythm Society (HRS) 2017 on leadless pacing technologies

Cardiovascular Business | November 09, 2017

A discussion with Peter L. Duffy, M.D., MMM, FACC, FSCAI CPE, interventional cardiologist and former director of quality for the cardiovascular service line at FirstHealth of the Carolinas Reid Heart Institute, at Moore Regional Hospital in Pinehurst, N.C. Read the article with Duffy “Interventional Cardiologist Redefines Value for Everyday Medical Practice.” Read the article “Preparing Hospitals for Mandatory Medicare Cardiac Bundled Payments.”

Hemodynamic Support Devices | November 09, 2017

A discussion with William W. O’Neill, M.D., medical director, Center for Structural Heart Disease, Henry Ford Hospital, Detroit, about the creation of a national initiative to start percutaneous hemodynamic support first before beginning revascularization. O’Neill started the Detroit Cardiogenic Shock Initiative with several hospitals in 2016 and saw a 50 percent drop in mortality. Read the article “Detroit Cardiogenic Shock Initiative Goes National at TCT 2017.” Watch the VIDEO “Cardiogenic Shock Supported With Impella Shows Good Outcomes.”

Structural Heart Occluders | November 08, 2017

John Rhodes, M.D., co-director of the adult congenital heart program, Medical University of South Carolina, is the principal investigator for the REDUCE Trial, the FDA pivotal study using the Cardioform for PFO closure to prevent cryptogenic stroke. He discusses some of the data showing benefit for patients and debate around all the trials for PFO closure.

The FDA cleared the additional indication for PFO in April 2018.

Read about the results of the REDUCE trial in the article “PFO Closure Shows Positive Results from REDUCE Clinical Study.” Read about the approval of the first PFO closure device in 2016.  Watch the VIDEO "Addressing Adult Congenital Heart Referrals."

Cath Lab | November 08, 2017

Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on what technologies he predicts will become main stream therapies in the coming years. DAIC spoke to him at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. Read the article “The Future of Cardiology: 17 Technologies to Watch.” Watch other VIDEOS with Granada, “Transcatheter Mitral Valve Therapies in Development.” “The Evolution of TAVR Technology,” and “Bioresorbable Stent Failure Modes, Technique, Patient Selection and Future Development.”

Heart Valve Technology | November 08, 2017

Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at Morristown Medical Center, part of Atlantic Health System, explains the EARLY TAVR trial evaluating the use of transcatheter aortic valve replacement compared to surveilLance for patients With asymptomatic severe aortic stenosis. Genereux is the principal investigator for the trial. Read more about the EARLY TAVR trial

Heart Valve Technology | November 08, 2017

Stephen Worthley, MB, BS, Ph.D., director of cardiac catheterization, University of Adelaide, Australia, presents the MAVERIC Trial six-month outcomes using the Arto System at a press conferences at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. Read more about the trial in the article “Arto System Shows Promise as Less-Invasive Therapy for Heart Failure Patients.” Watch a VIDEO interview with Worthley on “Drug-Filled Stents as an Alternative to Polymer Drug Carriers.” 

Stents Bioresorbable | November 07, 2017

A discussion with Ajay Kirtane, M.D., SM, director of the cardiac catheterization laboratories at New York-Presbyterian Hospital/Columbia University Medical Center, on the ABSORB III 3-year outcomes and other Absorb data presented at TCT 2017. He explains more on the poor outcomes for the bioresorbable stent compared to the Xience metallic stent and procedural issues based on operator technique and experience. Read the article “Abbott Will End Sales of Absorb Bioresorbable Stent.” Watch the VIDEO “Bioresorbable Stent Comparable to Xience at Two Years, With Concerns,” with Stephen Ellis, M.D. Watch the VIDEO “Poor Outcomes for Bioresorbable Stents in Small Coronary Arteries,” with Gregg Stone, M.D.

Heart Valve Technology | November 07, 2017

Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, explains the current state of transcatheter mitral valve technologies in development and in trials. He is involved in some of these trials and was the principal investigator for the pivotal MitraClip trial. Watch the VIDEO “Transcatheter Mitral Valve Technology, Anatomical Challenges” with Juan Granada, M.D.. Read the articles “Advances and Future Directions for Transcatheter Valves,” and “Transcatheter Mitral Valve Replacement Devices in Development.”

Heart Valve Technology | October 27, 2017

Adam Greenbaum, M.D., co-director of the structural heart program at Henry Ford Health System in Detroit, discusses the innovative approach to transcatheter aortic valve replacement (TAVR) being pioneered at HFHS. Read the article "How to Perform Transcaval TAVR Access."

Read "Henry Ford Hospital Cardiologist Receives National Award for Innovating Transcaval Heart Procedure." 

Heart Valve Technology | October 23, 2017

A discussion with Mario Goessl, M.D., Ph.D., director of research and education at the Minneapolis Heart Institute. He presented research at ACC.17 on the cost savings and reduced patient recovery time achieved by using conscious sedation during transcatheter aortic valve repair (TAVR) procedures. Read the articles "Conscious Sedation TAVR Reduced Length-of-Stay and Hospital Costs," and "Moderate Sedation Shows Promise for TAVR Patients."

Chronic Total Occlusion (CTO) | October 09, 2017

Bill Lombardi, M.D., director of complex coronary artery interventions at the University of Washington, discusses the principles, training and technologies required for treating chronic total occlusions (CTOs) at ACC.17. Watch the VIDEO “New Technology to Treat Chronic Total Occlusions (CTOs)” with Farouc Jaffer, M.D., Ph.D., director of coronary interventions at Massachusetts General Hospital. Read the article “When to Consider Revascularization of Coronary Chronic Total Occlusions.”

Chronic Total Occlusion (CTO) | September 28, 2017

Farouc Jaffer, M.D., Ph.D., director of coronary interventions at Massachusetts General Hospital, discusses the newest advances and technologies for treating chronic total occlusions (CTOs) at ACC.17. Read the article "When to Consider Revascularization of Coronary Chronic Total Occlusions."

Structural Heart Occluders | September 13, 2017

Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Sidra Medical and Research Center in Doha, Qatar, discusses the latest technologies for ASD and PFO closure at ACC.17. Read the article “Closing Holes in the Heart.”
 

Overlay Init